Literature DB >> 14684222

State-of-the-art therapy for severe sepsis and multisystem organ dysfunction.

Samir S Awad1.   

Abstract

Despite spectacular advances in life-support technology, the management of patients with severe sepsis continues to be a significant health care challenge because of the associated major morbidity, high mortality, and health economic implications. Severe sepsis with associated multisystem organ dysfunction (MOD) is the leading cause of death in the intensive care unit. Recent understanding of the pathophysiology now demonstrates that the syndrome of severe sepsis after a major physiologic insult is characterized by the activation of multiple overlapping and interacting cascades leading to systemic inflammation, a procoagulant state, and decreased fibrinolysis, which if unchecked leads to the progressive functional deterioration of multiple interdependent organs. This review will highlight the epidemiology, current understanding of the pathophysiology, management, and prevention of the syndrome of severe sepsis with MOD.

Entities:  

Mesh:

Year:  2003        PMID: 14684222     DOI: 10.1016/j.amjsurg.2003.10.004

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Gender and acute respiratory distress syndrome in critically injured adults: a prospective study.

Authors:  Daithi S Heffernan; Lesly A Dossett; Michelle A Lightfoot; Richard D Fremont; Lorraine B Ware; Robert G Sawyer; Addison K May
Journal:  J Trauma       Date:  2011-10

Review 2.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

3.  Estradiol is associated with mortality in critically ill trauma and surgical patients.

Authors:  Addison K May; Lesly A Dossett; Patrick R Norris; Erik N Hansen; Randalyn C Dorsett; Kimberley A Popovsky; Robert G Sawyer
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

4.  Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  Wei-Jian Zhang; Hao Wei; Tory Hagen; Balz Frei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

5.  Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction.

Authors:  D Shane O'Mahony; W Conrad Liles; William A Altemeier; Shireesha Dhanireddy; Charles W Frevert; Denny Liggitt; Thomas R Martin; Gustavo Matute-Bello
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.

Authors:  Wei-Jian Zhang; Balz Frei
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

7.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.